In collaboration with Rarelab, we launched a survey with the aim of assessing the actual impact of the use of comparators in the negotiation of orphan drugs, drugs that for
The official European Commission proposal is scheduled to be published on 29 March 2023, but during the World Evidence, Pricing and Access Congress -
The 5% Fund for rare diseases, which allows access to medicines that are not yet marketed in Italy and represent a hope of cure for
On 30 November 2021, AIFA defined the new access criteria for Law 326/2003. This law was supplemented by the Law of 10 November 2021
On 26 May 2021, the Chamber of Deputies, after more than two years of work in the Social Affairs Commission, approved the bill promoting the
The Incisive Health Morning Club co-organised by Nomos Centro Studi Parlamentari and Pharma Value in cooperation with The Health Link was held on 20 May,
